What clinical trials are currently recruiting in Connecticut?

TrialFinder lists 1299 recruiting clinical trials with sites in or near Connecticut. Results cover a wide range of conditions and are updated regularly from ClinicalTrials.gov.

Do I need insurance to join a clinical trial in Connecticut?

No. Study-related care is covered by the trial sponsor at no cost to participants. This includes the experimental treatment, required lab tests, and study visits. Many trials also provide compensation for time and travel. Health insurance is not required to search or enroll.

What conditions have clinical trials recruiting in Connecticut?

Trials in Connecticut cover a broad range of conditions including cancer, diabetes, heart disease, neurological disorders, autoimmune diseases, mental health conditions, and more. Use TrialFinder to search by specific condition and location.

How do I sign up for a clinical trial in Connecticut?

Find a trial that matches your condition on TrialFinder, review the eligibility criteria, and contact the research site listed on the trial detail page. Most research teams will conduct a brief phone pre-screening before any in-person visit. You can also create a free TrialFinder profile to get matched to recruiting trials near you.

1299 Recruiting Trials

Clinical Trials
in Connecticut

Browse 1299 recruiting clinical trials currently enrolling participants in Connecticut. Search by condition to find trials you may qualify for, at no cost.

Showing 15 of 1299 recruiting trials in Connecticut

The Cancer of the Pancreas Screening-5 CAPS5)Study

PHASE3 New Haven, Connecticut +4 sites · Lynch Syndrome, Pancreas Cancer

Recruiting

Collection and Storage of Tissue and Blood Samples From Patients With Cancer

N/A Birmingham, Alabama +4 sites · Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm

Recruiting

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

PHASE3 Anchorage, Alaska +4 sites · Stage IV Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8

Recruiting

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

PHASE3 Anchorage, Alaska +4 sites · Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8

Recruiting

Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung

PHASE2 Anchorage, Alaska +4 sites · Advanced Extrapulmonary Neuroendocrine Carcinoma, Metastatic Extrapulmonary Neuroendocrine Carcinoma

Recruiting

Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy

PHASE3 Chandler, Arizona +4 sites · Open Tíbia Fracture, Open tíbia Fracture

Recruiting

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

PHASE3 Birmingham, Alabama +4 sites · Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8

Recruiting

The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema

NA New Haven, Connecticut +4 sites · Lymphedema, Breast Cancer

Recruiting

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

PHASE2 Phoenix, Arizona +4 sites · Muscle Invasive Bladder Urothelial Carcinoma, Stage IV Bladder Urothelial Carcinoma AJCC v7

Recruiting

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

PHASE3 Birmingham, Alabama +4 sites · Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8

Recruiting

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

PHASE3 Fayetteville, Arkansas +4 sites · Stage IV Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8

Recruiting

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

PHASE3 Phoenix, Arizona +4 sites · Metastatic Dedifferentiated Liposarcoma, Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8

Recruiting

Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma

PHASE1 Phoenix, Arizona +4 sites · Refractory Multiple Myeloma, Recurrent Multiple Myeloma

Recruiting

The Impact of Music Medicine on Preterm Brain Development and Behavior

NA New Haven, Connecticut +1 sites · Stress, Infant Development

Recruiting

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

PHASE2 Chandler, Arizona +4 sites · Non-Small Cell Lung Cancer, c-MET

Recruiting

See all 1299 results in Connecticut

Check Your Eligibility

Create a free profile and our AI will match you to trials in Connecticut you may qualify for.

Get Matched — Free

No insurance required

Search by Condition in Connecticut

Diabetes Cancer Breast Cancer Depression Anxiety Alzheimer's Heart Disease Asthma Multiple Sclerosis Obesity Parkinson's Lupus Hypertension COPD Stroke Arthritis Kidney Disease COVID-19

Browse Other States

California Texas New York Florida Illinois Pennsylvania Ohio Georgia North Carolina Michigan New Jersey Washington Arizona Massachusetts Tennessee Colorado Minnesota Maryland Wisconsin Oregon

Clinical Trialsin Connecticut

Showing 15 of 1299 recruiting trials in Connecticut

Check Your Eligibility

Clinical Trials
in Connecticut